Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease characterized by hepatocellular inflammation, necrosis, and fibrosis, which can progress to cirrhosis and fulminant hepatic failure. The standard treatment for AIH includes corticosteroids alone or in combination with azathioprine. Although most patients achieve remission using the standard regimen, some patients do not respond due to either drug intolerance or refractory disease; in such cases alternative immunosuppressive agents should be explored. The second-line therapies are cyclophilin inhibitors such as cyclosporine A or tacrolimus, and nowadays mycophenolate mofetil (MMF) is widely used if azathioprine-based therapies are not tolerated. Although these are recommended as an alternative to the first-line regimen, there is insufficient evidence for the efficacy of second-line therapies, with the evidence based mainly on expert opinion. Therefore, we report an AIH patient receiving the standard regimen in whom remission did not occur due to side effects to azathioprine, but was successfully treated with MMF in combination with corticosteroids as an alternative to the standard regimen.
Citations
Citations to this article as recorded by
Revealing the pathogenesis of autoimmune hepatitis and research progress in drug discovery from hepatic immune cells and intercellular communication signaling mechanisms Jie Yang, Hongying Zhou, Xiao Ma, Xuelin Zhou, Shizhang Wei, Yanling Zhao, Chunyu Li Frontiers in Immunology.2026;[Epub] CrossRef
Cytopenias in Autoimmune Liver Diseases—A Review Mohammed Abdulrasak, Ali M. Someili, Mostafa Mohrag Journal of Clinical Medicine.2025; 14(5): 1732. CrossRef
Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study Gang Chi, Jinhong Pei, Xueqing Li, Alessandro Granito PLOS ONE.2024; 19(6): e0305220. CrossRef
Mycophenolate mofetil as a treatment for presumed idiopathic chronic hepatitis in dogs: Six cases (2010–2022) Michelle K. Beehler, Shawn A. Kearns, Zachary J. Crouse Veterinary Medicine and Science.2023; 9(6): 2527. CrossRef
Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das Toxicology Reports.2021; 8: 376. CrossRef
Human Cytomegalovirus Upregulates Expression of HCLS1 Resulting in Increased Cell Motility and Transendothelial Migration during Latency Yusuf Aslam, James Williamson, Veronika Romashova, Elizabeth Elder, Benjamin Krishna, Mark Wills, Paul Lehner, John Sinclair, Emma Poole iScience.2019; 20: 60. CrossRef
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy Stuart K. Roberts, Ricky Lim, Simone Strasser, Amanda Nicoll, Alessia Gazzola, Joanne Mitchell, Way Siow, Tiffany Khoo, Zaki Hamarneh, Martin Weltman, Paul Gow, Natasha Janko, Edmund Tse, Gauri Mishra, En-Hsiang Cheng, Miriam Levy, Wendy Cheng, Siddharth Clinical Gastroenterology and Hepatology.2018; 16(2): 268. CrossRef
Alternative treatment regimens in autoimmune hepatitis: how justified is their choice? M. V. Matsievich, A. O. Bueverov, M. Yu. Petrachenkova Almanac of Clinical Medicine.2018; 46(5): 504. CrossRef
Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta‑analysis Feng‑Bin Lu, En‑De Hu Hu, Lan‑Man Xu, Yi‑Bing Hu, Lu Chen, Jin‑Lu Wu, Hui Li, Da‑Zhi Chen, Yong‑Ping Chen Experimental and Therapeutic Medicine.2018;[Epub] CrossRef
Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba Marlen Ivón Castellanos Fernández, Deyanira la Rosa Hernández, Diego Enrique Cabrera Eugenio, Wilson Palanca, Zaily Dorta Guridi, Licet González Fabián Current Therapeutic Research.2017; 85: 8. CrossRef
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani World Journal of Gastroenterology.2017; 23(33): 6030. CrossRef
First
Prev
